Evidence map›Paper›PMID 23110705›Full record

ArticleRetrovirology2012

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.

Hongshuo Song, Jeffrey W Pavlicek, Fangping Cai, Tanmoy Bhattacharya, Hui Li, Shilpa S Iyer, Katharine J Bar, Julie M Decker, Nilu Goonetilleke, Michael K P Liu and 13 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Modelling andVirus evolution · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Hongshuo SongDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA. fgao@duke.edu
Jeffrey W Pavlicek
Fangping Cai
Tanmoy Bhattacharya
Hui Li
Shilpa S Iyer
Katharine J Bar
Julie M Decker
Nilu Goonetilleke
Michael K P Liu
Anna Berg
Bhavna Hora
Mark S Drinker
Josh Eudailey
Joy Pickeral
M Anthony Moody
Guido Ferrari
Andrew McMichael
Alan S Perelson
George M Shaw
Beatrice H Hahn
Barton F Haynes
Feng Gao
Duke Medical Center · USUniversity of Pennsylvania · USUniversity of Oxford · GBLos Alamos National Laboratory · USMRC Weatherall Institute of Molecular Medicine · GBSanta Fe Institute · USUniversity of Alabama at Birmingham · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI LETVIN, NORMAN L · 2006 to 2011
$290.5M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
Modeling Viral and T Lymphocyte DynamicsR01OD011095 · OD · TRIAD NATIONAL SECURITY, LLC · PI PERELSON, ALAN S · 2012 to 2024
$5.0M
Immune System Modeling/HIVR01AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1990 to 2021
$3.7M
Immune System Modeling/HIVR37AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 2002 to 2011
$2.4M
NIAID NIH HHS AI028433NIAID NIH HHS AI067854NIAID NIH HHS R01 AI028433NIAID NIH HHS U19 AI067854NIH HHS OD011095NIH HHS R01 OD011095
6 · The paper itself

Abstract

backgroundA modest change in HIV-1 fitness can have a significant impact on viral quasispecies evolution and viral pathogenesis, transmission and disease progression. To determine the impact of immune escape mutations selected by cytotoxic T lymphocytes (CTL) on viral fitness in the context of the cognate transmitted/founder (T/F) genome, we developed a new competitive fitness assay using molecular clones of T/F genomes lacking exogenous genetic markers and a highly sensitive and precise parallel allele-specific sequencing (PASS) method.

resultsThe T/F and mutant viruses were competed in CD4+ T-cell enriched cultures, relative proportions of viruses were assayed after repeated cell-free passage, and fitness costs were estimated by mathematical modeling. Naturally occurring HLA B57-restricted mutations involving the TW10 epitope in Gag and two epitopes in Tat/Rev and Env were assessed independently and together. Compensatory mutations which restored viral replication fitness were also assessed. A principal TW10 escape mutation, T242N, led to a 42% reduction in replication fitness but V247I and G248A mutations in the same epitope restored fitness to wild-type levels. No fitness difference was observed between the T/F and a naturally selected variant carrying the early CTL escape mutation (R355K) in Env and a reversion mutation in the Tat/Rev overlapping region.

conclusionsThese findings reveal a broad spectrum of fitness costs to CTL escape mutations in T/F viral genomes, similar to recent findings reported for neutralizing antibody escape mutations, and highlight the extraordinary plasticity and adaptive potential of the HIV-1 genome. Analysis of T/F genomes and their evolved progeny is a powerful approach for assessing the impact of composite mutational events on viral fitness.

Indexed as

Genetic FitnessGenome, ViralMutationBase SequenceCD4-Positive T-LymphocytesCells, CulturedEpitopes, T-LymphocyteFounder Effectgag Gene Products, Human Immunodeficiency VirusHIV-1HLA-B AntigensHumansImmune EvasionMolecular Sequence Datarev Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency VirusEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusHLA-B57 antigenHLA-B Antigensrev Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID23110705
PMCPMC3496648
OpenAlexW2147233961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.